Loading…
Prognostic significance of pronormoblasts in erythrocyte predominant myelodysplastic patients
Recent studies of acute erythroleukemias have reaffirmed DiGuglielmo's syndrome (M6a, myeloblast‐predominant) and disease (M6b, pronormoblast‐predominant). M6c (mixed myeloblast/pronormoblast) has also been described. However, MDS is still defined according to the percentage of myeloblasts (% m...
Saved in:
Published in: | American journal of hematology 2006-07, Vol.81 (7), p.484-491 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Recent studies of acute erythroleukemias have reaffirmed DiGuglielmo's syndrome (M6a, myeloblast‐predominant) and disease (M6b, pronormoblast‐predominant). M6c (mixed myeloblast/pronormoblast) has also been described. However, MDS is still defined according to the percentage of myeloblasts (% myeloblasts) without including the pronormoblast count.
A 20‐year retrospective study was performed to identify cases demonstrating ≥50% erythrocytic component and |
---|---|
ISSN: | 0361-8609 1096-8652 |
DOI: | 10.1002/ajh.20563 |